| |
|
|
|
Oramed Pharmaceuticals Inc.  
|
|
3.92 -0.08 (-0.02%) |
12-14 13:24 |
|
Open: |
3.9766 |
Pre close: |
4 |
Target:
|
4.99 
|
|
High: |
3.9801 |
Low: |
3.9001 |
Resistance:
|
4.27
4.50
|
|
Volume: |
22,319 |
Market Cap: |
68M |
Support:
|
3.90
3.24
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.01
|
MACD |
MACD(12,26):
|
-0.07 |
|
MA(20): |
4.08 |
Signal(12,26,9): |
-0.07 |
|
MA(100): |
4.59 |
Stochastic Oscillator |
%K(14,3):
|
10.42 |
|
MA(250): |
6.28 |
%D(3): |
15.01 |
|
Average Volume(K) |
3-Month: |
2466
|
52-Week |
High:
|
9.48 |
|
10-Days: |
2742 |
Low: |
3.90 |
|
RSI |
RSI(14):
|
39.11 |
Change(%): |
-54.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.880 |
Return on Equity (ttm) |
-50.5 |
Shares Out. (M) |
17.38 |
|
EPS Est. Current Year |
-0.780 |
Return on Assets (ttm) |
-29.6 |
Shares Float (M) |
0.00 |
|
EPS Est. Next Year |
-1.250 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.270 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
7.10 |
|
Forward EPS |
-1.521 |
Gross Profit (p.s.) |
0.035 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
2.280 |
EBITDA (p.s.) |
-0.144 |
P/E |
-4.45 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.72 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-12.06 |
P/S |
400762368.00 |
|
Operating Margin |
-540.00 |
Levered Free Cash Flow
(M) |
-5.57 |
P/CF |
-5.65 |
|
|
|
|
|
|
